Children’s Medical Center Dallas (Children’s) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children. Pediatric strokes is a little-known condition that occurs as often as leukemia and brain tumors but often is not recognized by parents or physicians, despite the serious short- and long-term health consequences. As part of this effort, Children’s will be one of four research sites in North America participating in this groundbreaking research.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/childrens/48624/
According to a new report, How Can We Avoid a Stroke Crisis in the Asia-Pacific Region?, urgent coordinated action is needed to avoid millions of preventable strokes, which leave many patients who have atrial fibrillation (AF) both mentally and physically disabled, or dead, every year.
The report, launched today during the 18th Asian Pacific Congress of Cardiology (APCC) by Action for Stroke Prevention, a group of health experts from across the globe, proposes urgent measures to prevent stroke in Asia-Pacific patients with AF, the most common, sustained abnormal heart rhythm and a major cause of stroke. The report’s recommendations are endorsed by 32 leading Asia-Pacific and other global medical societies and patient organizations, reinforcing and recognizing the need for a call to action.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/strikeoutstroke/48909/
Urgent coordinated action from national governments, medical societies and patient organizations is needed to avoid a public health crisis resulting from the tide of preventable strokes that leave many people with atrial fibrillation (AF) mentally and physically disabled or dead, every year. How Can We Avoid a Stroke Crisis in Latin America?, a report from Action for Stroke Prevention – a group of health experts from around the world - reveals the huge economic, social and personal burden of AF-related strokes across the region. Launched today at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 3rd Latin America Conference, the report proposes measures to tackle stroke in patients with AF, the most common, sustained abnormal heart rhythm and a major cause of stroke.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/strikeoutstroke/50549/
Ahead of World Stroke Day 2012 (October 29), European Policy Makers have joined over 90 Medical and Patient Organisations, and more than 100,000 people, in supporting the Global Atrial Fibrillation (AF) Patient Charter and calling for National Governments and the World Health Organisation to act to make the prevention of AF-related strokes a priority. The Charter outlines ways to improve the diagnosis and management of AF which, if implemented, could stop thousands of preventable strokes from occurring each and every year.
To view Multimedia News Release, go to http://www.multivu.com/players/English/57497-sign-against-stroke/
Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology.
The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks.
To view the multimedia release go to:
https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
Chinese Strokes Order is the easy way to learn Chinese writing and calligraphy. Learn not only to write and recognize Chinese characters, but also to understand their meaning.
http://hellolearnchinese.com
